Organization: Health Canada
Year: 2021
Month: August
Request Number: A-2020-001894
Request Summary: Adverse Reaction Reports (AERs) for Ondansetron. Report numbers: E2B_03280809, E2B_03289700, E2B_03322101. (ADRs) for Pantoloc. Report numbers: E2B_03306917, 920093. (ADRs) for Pantoprazole Sodium. Report numbers: E2B_03283751, E2B_03293332, E2B_03301666. (ADRs) for Pantoprazole Magnesium. Report numbers: E2B_03330338, E2B_03323855. (ADR) for Alunbrig. Report number: E2B_03309858. (ADR) for Guanfacine (guanfacine hydrochloride). Report number: E2B_03302980.
Disposition: Disclosed in part
Number of pages: 548